fluoxetine 20mg hard capsules
bristol laboratories limited - fluoxetine - capsule, hard - 20 milligram(s) - selective serotonin reuptake inhibitors; fluoxetine
fluoxetine 60 mg hard capsules
bristol laboratories limited - fluoxetine - capsule, hard - 60 milligram(s) - selective serotonin reuptake inhibitors; fluoxetine
atazanavir teva 150 mg capsules, hard
teva b.v. - atazanavir sulfate - capsule, hard - 150 milligram(s) - protease inhibitors; atazanavir - protease inhibitor - atazanavir teva capsules, co-administered with low dose ritonavir, are indicated for the treatment of hiv-1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products. based on available virological and clinical data from adult patients, no benefit is expected in patients with strains resistant to multiple protease inhibitors ( 4 pi mutations). there are very limited data available from children aged 6 to less than 18 years
atazanavir teva 200 mg capsules, hard
teva b.v. - atazanavir sulfate - capsule, hard - 200 milligram(s) - protease inhibitors; atazanavir - protease inhibitor - atazanavir teva capsules, co-administered with low dose ritonavir, are indicated for the treatment of hiv-1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products. based on available virological and clinical data from adult patients, no benefit is expected in patients with strains resistant to multiple protease inhibitors ( 4 pi mutations). there are very limited data available from children aged 6 to less than 18 years
atazanavir teva 300 mg capsules, hard
teva b.v. - atazanavir sulfate - capsule, hard - 300 milligram(s) - protease inhibitors; atazanavir - protease inhibitor - atazanavir teva capsules, co-administered with low dose ritonavir, are indicated for the treatment of hiv-1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products. based on available virological and clinical data from adult patients, no benefit is expected in patients with strains resistant to multiple protease inhibitors ( 4 pi mutations). there are very limited data available from children aged 6 to less than 18 years (
lenalidomide synthon capsules hard 2.5mg
synthon bv microweg 22, 6545 cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 2.5 milligram(s) - immunosuppressants
lenalidomide synthon capsules hard 5mg
synthon bv microweg 22, 6545 cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 5 milligram(s) - immunosuppressants
lenalidomide synthon capsules hard 7.5mg
synthon bv microweg 22, 6545 cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 7.5 milligram(s) - immunosuppressants
lenalidomide synthon capsules hard 10mg
synthon bv microweg 22, 6545 cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 10 milligram(s) - immunosuppressants
lenalidomide synthon capsules hard 15mg
synthon bv microweg 22, 6545 cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 15 milligram(s) - immunosuppressants